Conquest Advisors的封面图片
Conquest Advisors

Conquest Advisors

生物技术研究

Alexandria，Virginia 80 位关注者

We serve our clients so that they may fully realize their investment in developing life-changing biopharmaceuticals

关注

关于我们

We have one mission, to serve our clients by leveraging our expertise in economics, medical, policy, government affairs, advocacy, and media so that they may fully realize their investment in developing life-changing biopharmaceuticals and devices. Our team of experts will help established and emerging companies enhance their sophistication leading to a greater return on their investment. Our team includes experts have several decades of experience in and with: ? Health Economics and Outcomes Research (HEOR) ? Phase IV Clinical Trials and Medical Affairs ? Regulatory Approval Pathway and Policy ? Earned and Social Media ? Healthcare Policy (State and Federal) ? Lobbying (State and Federal) ? Provider and Patient Alliance Development (Including Coalition Building) ? Scope of Practice ? Employers Biopharmaceutical Benefits Established Content in: ? Payment Reform for Established and New Therapies ? Drug Pricing, Spending, Affordability and Access o Rebates Contracting o Reference Pricing, International Price Index and Most Favored Nation o Health Information Technology Assessment – ICER, NICE and IQWiG o Accumulators and Maximizers o Patient Assistance Programs o 340B Program o Administrative Burden – Step Therapy and Prior Authorization o Medication Adherence Policies and Technologies ? Generic and Authorized Generic Pricing and Access ? Research and Development Payment and Policy ? Therapeutic Areas of Focus o Vaccines o Biosimilars o Nutraceuticals o Rare and Ultra Rare Diseases o Orphan Drugs o Cell and Gene Therapies

网站
https://conquest-advisors.com/
所属行业
生物技术研究
规模
1 人
总部
Alexandria，Virginia
类型
自有
创立
2021

地点

  • 主要

    6301 Edsall Rd

    Unit 218

    US，Virginia，Alexandria，22312

    获取路线

Conquest Advisors员工

查看全部员工

动态

  • New Policy Paper: Challenges in Adult Vaccination: Policy Strategies for Sustaining Access and Supply Key Takeaways: Adult vaccination spending as a share of total pharmaceutical expenditure in the US is 1.2% (less than in Canada!) Pharmacies and pharmacists in the U.S. for the past couple of decades have created unprecedented access ecosystem to adult immunization despite draconian state scope of practice laws There is precedence that a robust and competitive vaccine market is necessary to prevent shortages - note, flu vaccine shortage earlier in 2000's PBMs are now looking at the vaccine market as an opportunity to unleash their contracting methodology to pad their profits - they have not had a role in the vaccine market since all adult vaccines must be covered at no cost to the patient AND pharmacies through aggressive negotiation with pharmaceutical companies have kept prices and spending in check - note bullet one Historically, when PBM contracting gets involved in the biopharmaceutical market 3, things happen: Access is diminished for patients List prices increase while net prices flatline - note Senate Finance Report regarding insulin pricing and many other reports Healthcare professional reimbursement is reduced - note the plight of community and retail pharmacies Press Release:? https://lnkd.in/eYPvHr8T Paper:? https://lnkd.in/e63W2SiE

相似主页